E
Effrosyni D. Manali
Researcher at National and Kapodistrian University of Athens
Publications - 108
Citations - 2190
Effrosyni D. Manali is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 23, co-authored 89 publications receiving 1647 citations. Previous affiliations of Effrosyni D. Manali include Cleveland Clinic & Paris Diderot University.
Papers
More filters
Journal ArticleDOI
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
Pierre-Antoine Juge,Joyce S. Lee,Esther Ebstein,Hiroshi Furukawa,Evgenia Dobrinskikh,Steven Gazal,Caroline Kannengiesser,Sébastien Ottaviani,Shomi Oka,Shigeto Tohma,Naoyuki Tsuchiya,Jorge Rojas-Serrano,Montserrat I González-Pérez,Mayra Mejía,Ivette Buendía-Roldán,Ramcés Falfán-Valencia,Enrique Ambrocio-Ortiz,Effrosyni D. Manali,Spyros Papiris,Theofanis Karageorgas,Dimitrios Boumpas,Katarina M. Antoniou,Coline H.M. van Moorsel,Joanne J. van der Vis,Yaël A de Man,Jan C. Grutters,Yaping Wang,Raphael Borie,Lidwine Wemeau-Stervinou,Benoit Wallaert,René-Marc Flipo,Hilario Nunes,Dominique Valeyre,Nathalie Saidenberg-Kermanac’h,Marie-Christophe Boissier,Sylvain Marchand-Adam,Aline Frazier,Pascal Richette,Yannick Allanore,Jean Sibilia,Claire Dromer,Christophe Richez,Thierry Schaeverbeke,Huguette Lioté,Gabriel Thabut,Nadia Nathan,S. Amselem,Martin Soubrier,Vincent Cottin,Annick Clement,Kevin D. Deane,Avram D Walts,Tasha E. Fingerlin,Aryeh Fischer,Jay H. Ryu,Eric L. Matteson,Timothy B Niewold,Deborah Assayag,Andrew J. Gross,Paul J. Wolters,Marvin I. Schwarz,Michael Holers,Joshua J. Solomon,Tracy J. Doyle,Ivan O. Rosas,Cornelis Blauwendraat,Michael A. Nalls,Marie-Pierre Debray,Catherine Boileau,Bruno Crestani,David A. Schwartz,Philippe Dieudé +71 more
TL;DR: It is found that the MUC5B promoter variant was associated with rheumatoid arthritis and more specifically associated with evidence of usual interstitial pneumonia on imaging and associated with an increased risk of ILD among patients with RA.
Journal ArticleDOI
Amiodarone: review of pulmonary effects and toxicity.
Spyros Papiris,Christina Triantafillidou,Likurgos Kolilekas,Despoina Markoulaki,Effrosyni D. Manali +4 more
TL;DR: The development of lung complications appears to be associated with older age, duration of treatment and cumulative dosage, high levels of its desethyl metabolite, history of cardiothoracic surgery and/or use of high oxygen mixtures, use of iodinated contrast media and probably pre-existing lung disease as well as co-existing respiratory infections.
Journal ArticleDOI
Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.
Likurgos Kolilekas,Effrosyni D. Manali,Katerina Vlami,Panagiotis Lyberopoulos,Christina Triantafillidou,Konstantinos Kagouridis,Katerina Baou,Sotirios Gyftopoulos,Konstantinos Vougas,Anna Karakatsani,Manos Alchanatis,Spyros Papiris +11 more
TL;DR: Evidence is provided that intermittent sleep oxygen desaturation significantly exceeds that of maximal exercise and is associated with survival in IPF patients, and this work implies the existence of a link between lung damage and apnea events resulting to the induction and severity of intermittent sleep breathing disorders that aggravate pulmonary arterial hypertension and influence IPF survival.
Journal ArticleDOI
High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.
Spyros Papiris,Ioannis Tomos,Anna Karakatsani,Aris Spathis,Ioanna Korbila,Antonis Analitis,Likurgos Kolilekas,Konstantinos Kagouridis,Stylianos Loukides,Petros Karakitsos,Effrosyni D. Manali +10 more
TL;DR: Assessment of pro‐inflammatory and pro‐fibrotic cytokines in the peripheral blood from stable and exacerbated IPF patients found high levels of IL‐6 and IL‐8 characterize early‐on IPF‐AEs and an increase in the levels ofIL‐ 6 andIL‐8 associates with worse outcome in all patients.
Journal ArticleDOI
Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment
C. Diamanti,Effrosyni D. Manali,M. Ginieri-Coccossis,Konstantinos Vougas,Kyriaki Cholidou,Evangelos Markozannes,Petros Bakakos,Ioannis Liappas,Manos Alchanatis +8 more
TL;DR: CPAP therapy improves QoL and lessens depressive symptoms in the authors' group of well-treated OSA patients, however, physical activity and energy expenditure did not present statistically significant improvement in the same group of Osa patients.